Paustenbach D, Galbraith D, Finley B. 2014. Letter to the Editor: Authors’ response to letters to the editor re: Interpreting cobalt blood concentrations in hip implant patients. Clin Toxicol 52(5):569–570.
Abstract
Excerpt: As we have noted here, we agree with Devlin and Pomerleau that monitoring implant patients for signs of hypothyroidism and polycythemia starting at blood or serum cobalt concentrations above 100 μg/L would be prudent. And, we agree that a collection of these data and a thoughtful interpretation of what was learned would be helpful in validating our recommendations.